Streamlining Appeals At FDA: A Modest Proposal
By Donald E. Segal, a partner in the Food, Drug and Device Group of the law firm Alston & Bird LLP, and Sharon D. Brooks, an associate in the firm’s Washington, D.C. office.
By Donald E. Segal, a partner in the Food, Drug and Device Group of the law firm Alston & Bird LLP, and Sharon D. Brooks, an associate in the firm’s Washington, D.C. office.